This kit provides quantitative measurement of interleukin-1β (IL-1β) in mouse samples, supporting research into innate immune activation, inflammasome signaling, and pyroptic inflammatory responses. Because IL-1β is often measured across both systemic and local tissue compartments to track NLRP3 inflammasome-driven inflammation, the kit is designed to accommodate diverse sample contexts within a single assay platform.
Detection Range: The 12.5–800 pg/ml range spans the concentrations typically observed in mouse serum and plasma during LPS challenge, sterile injury, or infection models, where circulating IL-1β can rise from near-undetectable baseline levels to hundreds of pg/ml. Most stimulated samples can be run neat or with minimal dilution, simplifying assay planning.
Sensitivity: At 3.125 pg/ml, the kit detects the low basal IL-1β levels present in unstimulated controls, naïve serum, or early time points following inflammasome priming—conditions where IL-1β concentrations often fall below 15 pg/ml.
Sample Compatibility: Validation across serum, plasma, tissue homogenates, and cell culture supernatants enables researchers to correlate systemic IL-1β levels with local tissue production and in vitro BMDM or dendritic cell stimulation data within a single study.
Assay Efficiency: Requiring only 50–100 µl and 1–5 hours, the protocol accommodates limited-volume samples from retro-orbital bleeds or small tissue biopsies while supporting same-day results across multi-group kinetic experiments.
This kit is directly applicable to studies of sepsis modeling, NLRP3 inflammasome activation, and colitis-associated mucosal inflammation.